As advocates for people with heart valve disease, we speak out for policies that will encourage early detection, create opportunities for meaningful help and support, and ensure timely access to appropriate treatments.
See below for a look at some of our recent policy positions.
April 2021 | Heart Valve voice US
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)
November 2020 | Heart Valve voice US
HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies
August 2020 | Heart Valve voice US
HVV US is advocating for patients with mitral valve disease. See our comments to CMS
May 2020 | Heart Valve voice US
Need for Patient Input Regarding Resumption of Cardiovascular Procedures
March 2019 | Heart Valve voice US
CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients